Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

Vertex Pharmaceuticals Incorporated ... The company’s pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX ...

Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...

Thailand has received 260 human trafficking victims, more than half of them Ethiopians, from Myanmar, its army said on Thursday, in a massive repatriation that comes amid a mounting crackdown on ...

VX-880 (formerly known as STx-02) derives from Vertex’ near $1 billion acquisition of Semma in 2019, and has started enrolling patients in a phase 1/2 study in the US. The therapy takes the form ...

2-Year U.S. Treasury Note Continuous Contract $102.750-0.012-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.500-0.008-0.01% 10-Year U.S. Treasury Note Continuous Contract $109.297-0.016 ...

A claim was initiated with the Standard on 12/4/2024. Two weeks following the required seven-day waiting period, my employee was expecting a STD benefit payment, none arrived. My organization paid ...

What is the current share price of Minerals 260 Limited (MI6)? Minerals 260 Limited's (MI6) current share price is $0.13. This constitutes a price movement of 0% when compared to the share price 7 ...

The company has successfully raised Rs 260 crore through Non-Convertible Debentures (NCDs), with the proceeds earmarked to drive initiatives in women empowerment, address territorial inequalities, and ...

At close: February 10 at 9:46:34 AM EST ...